Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan Heptinstall

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Platelets|November 4, 2008
Platelet function reduces significantly during the morningJane A May, Sue Fox, Jackie Glenn, et al.
Thrombosis Research|September 3, 2010
Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adultsMeyer M Samama, Satoshi Kunitada, Andŗe Oursin, et al.
Thrombosis and Haemostasis|September 28, 2002
Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirinRobert F Storey, Heather M Judge, Robert G Wilcox, et al.
Platelets|December 19, 2002
The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitroThomas Scholz, Lian Zhao, Uta Temmler, et al.
Platelets|April 13, 2005
Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromesMiles W H Behan, Susan C Fox, Stan Heptinstall, et al.
Platelets|January 10, 2004
P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonistLian Zhao, Philip M W Bath, Jane May, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2010
Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonistDavid Iyú, Jackie R Glenn, Ann E White, et al.
European Heart Journal|February 16, 2006
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirinSteen Husted, Håkan Emanuelsson, Stan Heptinstall, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2003
Mechanisms involved in adenosine triphosphate--induced platelet aggregation in whole bloodNicholas P Stafford, Andrew E Pink, Ann E White, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 21, 2006
Leukocytosis, vascular disease, and adenine nucleotide metabolismStan Heptinstall, Jacqueline R Glenn, Andrew Johnson, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Platelets|November 4, 2008
Platelet function reduces significantly during the morningJane A May, Sue Fox, Jackie Glenn, et al.
Thrombosis Research|September 3, 2010
Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adultsMeyer M Samama, Satoshi Kunitada, Andŗe Oursin, et al.
Thrombosis and Haemostasis|September 28, 2002
Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirinRobert F Storey, Heather M Judge, Robert G Wilcox, et al.
Platelets|December 19, 2002
The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitroThomas Scholz, Lian Zhao, Uta Temmler, et al.
Platelets|April 13, 2005
Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromesMiles W H Behan, Susan C Fox, Stan Heptinstall, et al.
Platelets|January 10, 2004
P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonistLian Zhao, Philip M W Bath, Jane May, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2010
Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonistDavid Iyú, Jackie R Glenn, Ann E White, et al.
European Heart Journal|February 16, 2006
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirinSteen Husted, Håkan Emanuelsson, Stan Heptinstall, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2003
Mechanisms involved in adenosine triphosphate--induced platelet aggregation in whole bloodNicholas P Stafford, Andrew E Pink, Ann E White, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 21, 2006
Leukocytosis, vascular disease, and adenine nucleotide metabolismStan Heptinstall, Jacqueline R Glenn, Andrew Johnson, et al.
Pageof 6